ABG Innovation Capital Partners III GP Ltd - PULMONX CORP ownership

PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
ABG Innovation Capital Partners III GP Ltd ownership history of PULMONX CORP
ValueSharesWeighting
Q4 2021$93,000
-42.9%
2,901
-35.8%
5.38%
-20.6%
Q3 2021$163,000
-18.1%
4,5210.0%6.77%
+916.8%
Q2 2021$199,000
-99.5%
4,521
-99.5%
0.67%
-96.4%
Q1 2021$38,117,000
-33.7%
833,3330.0%18.73%
-44.7%
Q4 2020$57,517,000833,33333.86%
Other shareholders
PULMONX CORP shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 994,971$10,278,0505.54%
ABG-WTT Global Life Science Capital Partners GP Ltd 60,204$621,9072.98%
PURA VIDA INVESTMENTS, LLC 726,298$7,502,6581.42%
CFM WEALTH PARTNERS LLC 264,039$2,727,5230.71%
BRAIDWELL LP 988,559$10,211,8140.32%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,017,958$10,515,5060.23%
Rock Springs Capital Management LP 652,400$6,739,2920.18%
Point72 Asset Management, L.P. 2,929,903$30,265,8980.09%
ALGERT GLOBAL LLC 117,327$1,2120.06%
Campbell & CO Investment Adviser LLC 45,380$468,7750.06%
View complete list of PULMONX CORP shareholders